Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
genentech
5
×
gene therapy
life sciences
national blog main
biotech
fda
national
national top stories
new york top stories
san francisco top stories
boston blog main
boston top stories
cell therapy
clinical trials
new york blog main
novartis
roche
san diego blog main
san diego top stories
san francisco
san francisco blog main
acetylon pharmaceuticals
acute lymphoblastic leukemia
africa
alector
alkermes
ambys medicines
avrobio
baricitinib
bcma
better ventures
billy dunn
biogen
bolt biotherapeutics
boulder/denver blog main
boulder/denver top stories
california
cancer
caribou biosciences
catalyst healthcare consultants
What
new
5
×
fda
gene
lack
therapy
treatments
advances
africa
aiming
ambys
apparent
approved
atrophy
available
big
bio
biopharma
biotech
century
change
chemistry
cmc
comes
congress
congressional
consistent
continent
control
controls
crispr
daily
deadly
deal
debuted
diseases
disregard
drug
ensure
entire
evrysdi
Language
unset
Current search:
genentech
×
new
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@techcrunch.com
4 years ago
Only 2% of genomic material available for research comes from Africa, 54gene wants to change that
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?